Study points to a workable serum handling window for canine miRNA

A new American Journal of Veterinary Research study offers encouraging news for veterinary teams working with emerging liquid-biopsy tools: immediate serum separation followed by refrigerated storage for 24 to 36 hours caused only minimal alterations in circulating microRNA levels in dogs. The study, by Janet A. Grimes and Brenna Webb, evaluated how different sample-handling conditions affect serum microRNA measurements, an issue that has become increasingly important as researchers explore microRNAs as diagnostic and prognostic biomarkers in canine disease. (pmc.ncbi.nlm.nih.gov)

That question matters because microRNA research in dogs has moved well beyond proof of concept. Reviews of the field show growing interest in circulating microRNAs for oncology, hepatobiliary disease, cardiology, and other applications, but they also consistently point to preanalytical variability as one of the biggest barriers to reproducibility. In other words, before a biomarker can be trusted in practice, clinicians and laboratories need confidence that sample collection and storage aren't driving the signal. (frontiersin.org)

According to the study abstract, the investigators collected whole blood from 10 healthy dogs and distributed samples across seven tubes representing different handling pathways. The control condition used a red-top tube that was centrifuged for immediate serum separation and then stored at −80 °C. Other conditions tested delays of 24 to 36 hours at room temperature or refrigerated temperature, including both separated serum and unprocessed red-top tubes. The headline finding was that immediate separation plus refrigerated storage led to minimal changes in circulating microRNA levels, supporting that workflow as a relatively stable short-term option. (pmc.ncbi.nlm.nih.gov)

The result fits with, but also helps refine, earlier literature. A 2017 canine study found that serum and plasma microRNAs were stable for only a short period and not after 24 hours at room temperature, underscoring the risks of delayed processing. More recent human and translational studies have shown that some circulating microRNAs can remain fairly stable under certain storage conditions, especially when handling is standardized, but reviews still caution that temperature, hemolysis, centrifugation, and tube type can all influence measured levels. This new canine paper adds species-specific evidence that refrigeration after immediate serum separation may reduce those artifacts. (pubmed.ncbi.nlm.nih.gov)

Direct outside commentary on this specific paper was limited in publicly available sources, but the broader expert consensus is clear: standardization is essential if circulating microRNAs are going to move from research settings into routine diagnostics. Reviews in veterinary and comparative literature repeatedly describe preanalytical conditions as a leading source of inconsistency, and they recommend tightly controlled collection and storage protocols to improve comparability across studies and laboratories. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, the practical value of this study is less about immediate clinical deployment and more about laboratory readiness. If a clinic can separate serum promptly and keep it refrigerated for up to 24 to 36 hours without materially shifting microRNA levels, that could make referral testing, batched processing, and multicenter research more feasible. It may be especially relevant for practices that don't have immediate access to ultra-low-temperature storage but do want to participate in biomarker studies or future send-out testing. At the same time, the study was small, included healthy dogs, and focused on analytical stability rather than diagnostic performance in disease, so it shouldn't be read as proof that every microRNA assay will behave the same way in clinical cases. (pmc.ncbi.nlm.nih.gov)

The paper also lands at a time when enthusiasm for canine microRNA biomarkers is being tempered by mixed disease-specific findings. Some studies have identified promising circulating microRNA candidates, while others, including recent work in chronic hepatitis, have found that selected serum microRNAs were not differentially expressed enough to support clinical use. That makes handling studies like this one especially important: even negative biomarker studies are easier to interpret when sample integrity is better controlled. (pmc.ncbi.nlm.nih.gov)

What to watch: The next step is validation in larger and more clinically diverse canine populations, along with protocol harmonization across institutions. Watch for whether future studies link this handling approach to specific disease assays, reference intervals, and commercial test development, because that's the point at which a useful preanalytical insight could begin to translate into day-to-day veterinary diagnostics. (frontiersin.org)